Soni Medicare
Soni Medicare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Soni Medicare
Start SIPSoni Medicare Investment Rating
-
Master Rating:
-
Sml Isuzu (Nse) has an operating revenue of Rs. 2,041.17 Cr. on a trailing 12-month basis. An annual revenue growth of 96% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 11% is good. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 76 which is a FAIR score but needs to improve its earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 96 indicates it belongs to a poor industry group of Auto Manufacturers and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 7 | 8 | 6 | 7 | 8 | 7 | 6 |
| Operating Expenses Qtr Cr | 8 | 7 | 7 | 7 | 8 | 6 | 6 |
| Operating Profit Qtr Cr | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
Soni Medicare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹28.04
- 50 Day
- ₹27.20
- 100 Day
- ₹26.22
- 200 Day
- ₹26.30
- 20 Day
- ₹27.85
- 50 Day
- ₹27.75
- 100 Day
- ₹24.76
- 200 Day
- ₹25.95
Soni Medicare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 28.05 |
| Second Resistance | 28.05 |
| Third Resistance | 28.05 |
| RSI | 51.24 |
| MFI | 59.12 |
| MACD Single Line | 0.30 |
| MACD | 0.27 |
| Support | |
|---|---|
| First Resistance | 28.05 |
| Second Resistance | 28.05 |
| Third Resistance | 28.05 |
Soni Medicare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 110 | 11,000 | 100 |
| Week | 342 | 34,225 | 100 |
| 1 Month | 429 | 42,853 | 100 |
| 6 Month | 541 | 54,051 | 100 |
Soni Medicare Result Highlights
Soni Medicare Synopsis
NSE-Auto Manufacturers
Sml Isuzu Ltd. is involved in the business activities of Manufacture of motor vehicles. Company’s Total Operating Revenue is Rs. 1821.59 Cr. and Equity Capital is Rs. 14.48 Cr. for the Year ended 31/03/2023. SML Isuzu Ltd. is a Public Limited Listed company incorporated on 26/07/1983 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L50101PB1983PLC005516 and registration number is 005516.| Market Cap | 2,041 |
| Sales | 2,041 |
| Shares in Float | 0.81 |
| No of funds | 16 |
| Yield | 0.78 |
| Book Value | 11.47 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | 9 |
| Alpha | 0.25 |
| Beta | 1.3 |
Soni Medicare
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 43.96% | 43.96% | 43.96% | 43.96% |
| Foreign Portfolio Investors | 0.28% | 0.11% | 1.68% | 1.69% |
| Individual Investors | 36.22% | 36.07% | 34.77% | 34.49% |
| Others | 19.54% | 19.86% | 19.59% | 19.86% |
Soni Medicare Management
| Name | Designation |
|---|---|
| Mr. S K Tuteja | Chairman |
| Mr. Junya Yamanishi | Managing Director & CEO |
| Mr. Sudhir Nayar | Director |
| Mr. Chandra Shekhar Verma | Director |
| Mr. Masaki Morohoshi | Director |
| Mr. Eiichi Seto | Director |
| Mr. Takuro Horikoshi | Director |
| Mr. Atima Khanna | Ind. Non-Executive Director |
| Mr. Takashi Nishida | Non Executive Director |
Soni Medicare Forecast
Price Estimates
Soni Medicare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-14 | Quarterly Results | (Revised) |
| 2023-08-14 | Quarterly Results | |
| 2023-05-29 | Audited Results | |
| 2023-02-13 | Quarterly Results | |
| 2022-11-14 | Quarterly Results |
Soni Medicare FAQs
What is Share Price of Soni Medicare ?
Soni Medicare share price is ₹28 As on 02 December, 2023 | 17:29
What is the Market Cap of Soni Medicare ?
The Market Cap of Soni Medicare is ₹12 Cr As on 02 December, 2023 | 17:29
What is the P/E ratio of Soni Medicare ?
The P/E ratio of Soni Medicare is -16.7 As on 02 December, 2023 | 17:29
What is the PB ratio of Soni Medicare ?
The PB ratio of Soni Medicare is 3.6 As on 02 December, 2023 | 17:29